<Record>
<Term>ZD4054</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Endothelin Receptor Antagonist</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Antineoplastic Agent/Angiogenesis Inhibitor/Miscellaneous Angiogenesis Inhibitor/Endothelin Receptor Antagonist/ZD4054</ClassificationPath>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>ZD4054</BroaderTerm>
<BroaderTerm>Endothelin Receptor Antagonist</BroaderTerm>
<BroaderTerm>Antineoplastic Agent</BroaderTerm>
<BroaderTerm>Angiogenesis Inhibitor</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Miscellaneous Angiogenesis Inhibitor</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>ZD4054</Synonym>
<Description>An orally available selective antagonist of the endothelin-A (ET-A) receptor with potential antineoplastic activity. ZD4054 binds selectively to the ET-A receptor, thereby inhibiting endothelin-mediated mechanisms that promote tumor cell proliferation. (NCI05)</Description>
<Source>NCI Thesaurus</Source>
</Record>
